Facebook
TwitterOfficial statistics are produced impartially and free from political influence.
Facebook
TwitterCoronavirus affects some members of the population more than others. Emerging evidence suggests that older people, men, people with health conditions such as respiratory and pulmonary conditions, and people of a Black, Asian Minority Ethnic (BAME) background are at particular risk. There are also a number of other wider public health risk factors that have been found to increase the likelihood of an individual contracting coronavirus. This briefing presents descriptive evidence on a range of these factors, seeking to understand at a London-wide level the proportion of the population affected by each.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Facebook
TwitterThis mapping tool enables you to see how COVID-19 deaths in your area may relate to factors in the local population, which research has shown are associated with COVID-19 mortality. It maps COVID-19 deaths rates for small areas of London (known as MSOAs) and enables you to compare these to a number of other factors including the Index of Multiple Deprivation, the age and ethnicity of the local population, extent of pre-existing health conditions in the local population, and occupational data. Research has shown that the mortality risk from COVID-19 is higher for people of older age groups, for men, for people with pre-existing health conditions, and for people from BAME backgrounds. London boroughs had some of the highest mortality rates from COVID-19 based on data to April 17th 2020, based on data from the Office for National Statistics (ONS). Analysis from the ONS has also shown how mortality is also related to socio-economic issues such as occupations classified ‘at risk’ and area deprivation. There is much about COVID-19-related mortality that is still not fully understood, including the intersection between the different factors e.g. relationship between BAME groups and occupation. On their own, none of these individual factors correlate strongly with deaths for these small areas. This is most likely because the most relevant factors will vary from area to area. In some cases it may relate to the age of the population, in others it may relate to the prevalence of underlying health conditions, area deprivation or the proportion of the population working in ‘at risk occupations’, and in some cases a combination of these or none of them. Further descriptive analysis of the factors in this tool can be found here: https://data.london.gov.uk/dataset/covid-19--socio-economic-risk-factors-briefing
Facebook
TwitterAs part of our ongoing mission to improve transparency, we are publishing minutes taken from meetings of the Commission on Human Medicines’ Vaccine Benefit Risk Expert Working Group (VBREWG) between 25 August 2020 and 5 May 2023. The VBREWG meetings focused on evaluating the safety, efficacy, and overall benefits versus risks of vaccines, providing expert advice and recommendations on licensing and regulatory action.
Under Section 40 and 43 of the Freedom of Information Act respectively, personal data of individuals and commercially sensitive information has been redacted from these minutes.
Facebook
Twitterhttps://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it. The purpose behind releasing this data is to present regional and local data to allow for its use in public health. It will also allow for greater analysis, modelling and planning to be performed using the latest data, to aid in the response to the pandemic. We will update this weekly and we would welcome your feedback to help us develop our open data sets. The data that is published is based on version 51 of the SPL clinical methodology, with the data extracted as at 28 March 2021.
Facebook
TwitterOpen Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Populations in the UK by risk of testing positive for COVID-19 from the Coronavirus (COVID-19) Infection Survey.
Facebook
TwitterBlack men and women in the United Kingdom were four times more likely to die from Coronavirus than white people of the same gender as of April 2020. Several other ethnic groups were also at an increased risk from Coronavirus than the white population, with men of Bangladeshi or Pakistani origin 3.6 times more likely, and women 3.4 more likely to die from Coronavirus.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Facebook
Twitterhttps://saildatabank.com/data/apply-to-work-with-the-data/https://saildatabank.com/data/apply-to-work-with-the-data/
The Chief Medical Officer (CMO) for England, working with the CMOs of the devolved nations and other senior clinicians, commissioned NHS Digital to produce a list of people at “high risk” of complications from COVID-19, who should be shielded for at least 12 weeks. The CMO for Wales commissioned a collaboration of national bodies in Wales (NWIS, DU, NWSSP, PHW) to identify “high risk” people for the Welsh population, based largely on the NHS Digital methodology. This list is referred to as the Shielded Patient List (SPL).
The “high risk” list was defined as a subset of a wider group of people who may be “at risk”. Specific advice applies to these groups, currently this advice is: • “At Risk” – large group normally at risk from the flu - should practice strict social distancing • “At high risk” – a smaller sub-group (circa 70k), defined by CMO – should practice complete social “shielding” NHS Digital have described the methodology that has been used to identify patients who meet the high risk criteria due to their inclusion in one or more of the disease groups.
As there are differences in some of the systems used across the devolved nations, nuanced differences in application and interpretation of CMO guidance, this document describes the Welsh methodology.
Dataset received it's final update in March 2022
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
BackgroundMinority ethnic groups are at increased risk of COVID-19 related mortality or morbidity yet continue to have a disproportionally lower uptake of the vaccine. The importance of adherence to prevention and control measures to keep vulnerable populations and their families safe therefore remains crucial. This research sought to examine the knowledge, perceived risk, and attitudes toward COVID-19 among an ethnically diverse community.MethodsA cross-sectional self-administered questionnaire was implemented to survey ethnic minority participants purposefully recruited from Luton, an ethnically diverse town in the southeast of England. The questionnaire was structured to assess participants knowledge, perceived risk, attitudes toward protective measures as well as the sources of information about COVID-19. The questionnaire was administered online via Qualtrics with the link shared through social media platforms such as Facebook, Twitter, and WhatsApp. Questionnaires were also printed into brochures and disseminated via community researchers and community links to individuals alongside religious, community and outreach organisations. Data were analysed using appropriate statistical techniques, with the significance threshold for all analyses assumed at p = 0.05.Findings1,058 participants (634; 60% females) with a median age of 38 (IQR, 22) completed the survey. National TV and social networks were the most frequently accessed sources of COVID-19 related information; however, healthcare professionals, whilst not widely accessed, were viewed as the most trusted. Knowledge of transmission routes and perceived susceptibility were significant predictors of attitudes toward health-protective practises.Conclusion/recommendationImproving the local information provision, including using tailored communication strategies that draw on trusted sources, including healthcare professionals, could facilitate understanding of risk and promote adherence to health-protective actions.
Facebook
TwitterBy Dan Winchester [source]
This dataset contains the total number of confirmed COVID-19 cases in each English Upper Tier Local Authority over the past eight days. Aggregated from Public Health England data, this dataset provides unprecedented insight into how quickly the virus has been able to spread in local communities throughout England. Despite testing limitations, understanding these localized patterns of infection can help inform important public health decisions by local authorities and healthcare workers alike.
It is essential to bear in mind that this data is likely an underestimation of true infection rates due to limited testing -- it is critical not to underestimate the risk the virus poses on a local scale! Use this dataset at your own discretion with caution and care; consider supplementing it with other health and socio-economic metrics for a holistic picture of regional trends over time.
This dataset features information surrounding GSS codes and names as well as total numbers of recorded COVID-19 cases per English Upper Tier Local Authority on January 5th 2023 (TotalCases_2023-01-05)
For more datasets, click here.
- 🚨 Your notebook can be here! 🚨!
- Comparing the total cases in each local authority to population density of the region, to identify areas with higher incidence of virus
- Tracking changes in total cases over a period of time to monitor trend shifts and detect possible outbreak hotspots
- Establishing correlations between the spread of COVID-19 and other non-coronavirus related health issues, such as mental health or cardiovascular risk factors
If you use this dataset in your research, please credit the original authors. Data Source
License: Dataset copyright by authors - You are free to: - Share - copy and redistribute the material in any medium or format for any purpose, even commercially. - Adapt - remix, transform, and build upon the material for any purpose, even commercially. - You must: - Give appropriate credit - Provide a link to the license, and indicate if changes were made. - ShareAlike - You must distribute your contributions under the same license as the original. - Keep intact - all notices that refer to this license, including copyright notices.
File: utla_by_day.csv | Column name | Description | |:--------------------------|:------------------------------------------------------------------------------------------------------| | GSS_CD | Government Statistical Service code for the local authority. (String) | | GSS_NM | Name of the local authority. (String) | | TotalCases_2023-01-05 | Total number of confirmed COVID-19 cases in the local authority on the 5th of January 2023. (Integer) |
If you use this dataset in your research, please credit the original authors. If you use this dataset in your research, please credit Dan Winchester.
Facebook
TwitterVaccinations in London Between 8 December 2020 and 15 September 2021 5,838,305 1st doses and 5,232,885 2nd doses have been administered to London residents. Differences in vaccine roll out between London and the Rest of England London Rest of England Priority Group Vaccinations given Percentage vaccinated Vaccinations given Percentage vaccinated Group 1 Older Adult Care Home Residents 21,883 95% 275,964 96% Older Adult Care Home Staff 29,405 85% 381,637 88% Group 2 80+ years 251,021 83% 2,368,284 93% Health Care Worker 174,944 99% 1,139,243 100%* Group 3 75 - 79 years 177,665 90% 1,796,408 99% Group 4 70 - 74 years 252,609 90% 2,454,381 97% Clinically Extremely Vulnerable 278,967 88% 1,850,485 95% Group 5 65 - 69 years 285,768 90% 2,381,250 97% Group 6 At Risk or Carer (Under 65) 983,379 78% 6,093,082 88% Younger Adult Care Home Residents 3,822 92% 30,321 93% Group 7 60 - 64 years 373,327 92% 2,748,412 98% Group 8 55 - 59 years 465,276 91% 3,152,412 97% Group 9 50 - 54 years 510,132 90% 3,141,219 95% Data as at 15 September 2021 for age based groups and as at 12 September 2021 for non-age based groups * The number who have received their first dose exceeds the latest official estimate of the population for this group There is considerable uncertainty in the population denominators used to calculate the percentage vaccinated. Comparing implied vaccination rates for multiple sources of denominators provides some indication of uncertainty in the true values. Confidence is higher where the results from multiple sources agree more closely. Because the denominator sources are not fully independent of one another, users should interpret the range of values across sources as indicating the minimum range of uncertainty in the true value. The following datasets can be used to estimate vaccine uptake by age group for London: ONS 2020 mid-year estimates (MYE). This is the population estimate used for age groups throughout the rest of the analysis. Number of people ages 18 and over on the National Immunisation Management Service (NIMS) ONS Public Health Data Asset (PHDA) dataset. This is a linked dataset combining the 2011 Census, the General Practice Extraction Service (GPES) data for pandemic planning and research and the Hospital Episode Statistics (HES). This data covers a subset of the population. Vaccine roll out in London by Ethnic Group Understanding how vaccine uptake varies across different ethnic groups in London is complicated by two issues: Ethnicity information for recipients is unavailable for a very large number of the vaccinations that have been delivered. As a result, estimates of vaccine uptake by ethnic group are highly sensitive to the assumptions about and treatment of the Unknown group in calculations of rates. For vaccinations given to people aged 50 and over in London nearly 10% do not have ethnicity information available, The accuracy of available population denominators by ethnic group is limited. Because ethnicity information is not captured in official estimates of births, deaths, and migration, the available population denominators typically rely on projecting forward patterns captured in the 2011 Census. Subsequent changes to these patterns, particularly with respect to international migration, leads to increasing uncertainty in the accuracy of denominators sources as we move further away from 2011. Comparing estimated population sizes and implied vaccination rates for multiple sources of denominators provides some indication of uncertainty in the true values. Confidence is higher where the results from multiple sources agree more closely. Because the denominator sources are not fully independent of one another, users should interpret the range of values across sources as indicating the minimum range of uncertainty in the true value. The following population estimates are available by Ethnic group for London:
Facebook
TwitterOpen Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Model estimates of deaths involving the coronavirus (COVID-19) by ethnic group for people in private households in England.
Facebook
Twitterhttps://www.pioneerdatahub.co.uk/data/data-request-process/https://www.pioneerdatahub.co.uk/data/data-request-process/
Frailty is a syndrome of increased vulnerability to incomplete resolution of homeostasis (healing or return to baseline function) following a stressor event (such as an infection or fall) and it is associated with poor outcomes including increased mortality and reduced quality of life. The pathophysiology of frailty is poorly understood. Age and frailty have been proven to be independently predictive of outcomes in patients admitted with an acute illness. In COVID-19, routine frailty identification informed decision making about treatment.
This dataset from 01-03-2020 to 01-04-2022 of 327,346 patients admitted during all waves of the COVID pandemic both with and without COVID-19. The dataset includes granular demographics, frailty scores, physiology and vital signs, all care contacts and investigations (including imaging), all medications including dose and routes, care outcomes, length of stay and outcomes including readmission and mortality.
Geography: The West Midlands (WM) has a population of 6 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & > 120 ITU bed capacity. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”.
Data set availability: Data access is available via the PIONEER Hub for projects which will benefit the public or patients. This can be by developing a new understanding of disease, by providing insights into how to improve care, or by developing new models, tools, treatments, or care processes. Data access can be provided to NHS, academic, commercial, policy and third sector organisations. Applications from SMEs are welcome. There is a single data access process, with public oversight provided by our public review committee, the Data Trust Committee. Contact pioneer@uhb.nhs.uk or visit www.pioneerdatahub.co.uk for more details.
Available supplementary data: Matched controls; ambulance and community data. Unstructured data (images). We can provide the dataset in OMOP and other common data models and can build synthetic data to meet bespoke requirements.
Available supplementary support: Analytics, model build, validation & refinement; A.I. support. Data partner support for ETL (extract, transform & load) processes. Bespoke and “off the shelf” Trusted Research Environment (TRE) build and run. Consultancy with clinical, patient & end-user and purchaser access/ support. Support for regulatory requirements. Cohort discovery. Data-driven trials and “fast screen” services to assess population size.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Relative risk of positive COVID-19 test by LTC groups (Poisson regression).
Facebook
TwitterAttribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
To record the information required to evaluate the potential risk of Covid-19 infection, as part of professional screening or self-assessment.
This is based on - The current NHS-111 UK self-assessment app at https://111.nhs.uk/covid-19 - A similar risk assessment app developed for pre-hospital admission by DIPS.no - Public Health England COVID-19: investigation and initial clinical management of possible cases https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases
The exact risk factors are subject to continual update as the disease progresses.
Note that a critical part of the information, exposure locations, has been left open, so as to allow the list to be updated very regularly and in alignment with local or national policy.
We have decided to leave in 'older' questions such as 'Exposure to birds in China' until such time that we get clear professional guidance that these are no longer necessary or useful.
Facebook
TwitterOpen Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Analysis of people previously considered to be clinically extremely vulnerable (CEV) in England during the coronavirus (COVID-19) pandemic, including their behaviours and mental and physical well-being.
Facebook
TwitterOpen Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Estimates of the risk of hospital admission for coronavirus (COVID-19) and death involving COVID-19 by vaccination status, overall and by age group, using anonymised linked data from Census 2021. Experimental Statistics.
Outcome definitions
For this analysis, we define a death as involving COVID-19 if either of the ICD-10 codes U07.1 (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified) is mentioned on the death certificate. Information on cause of death coding is available in the User Guide to Mortality Statistics. We use date of occurrance rather than date of registration to give the date of the death.
We define COVID-109 hospitalisation as an inpatient episode in Hospital Episode Statistics where the primary diagnosis was COVID-19, identified by the ICD-19 codes (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified). Where an individual had experienced more than one COVID-19 hospitalisation, the earliest that occurred within the study period was used. We define the date of COVID-19 hospitalisation as the start of the hospital episode.
ICD-10 code
U07.1 :
COVID-19, virus identified
U07.2:
COVID-19, virus not identified
Vaccination status is defined by the dose and the time since the last dose received
Unvaccinated:
no vaccination to less than 21 days post first dose
First dose 21 days to 3 months:
more than or equal to 21 days post second dose to earliest of less than 91 days post first dose or less than 21 days post second dose
First dose 3+ months:
more than or equal to 91 days post first dose to less than 21 days post second dose
Second dose 21 days to 3 months:
more than or equal to 21 days post second dose to earliest of less than 91 days post second dose or less than 21 days post third dose
Second dose 3-6 months:
more than or equal to 91 days post second dose to earliest of less than 182 days post second dose or less than 21 days post third dose
Second dose 6+ months:
more than or equal to 182 days post second dose to less than 21 days post third dose
Third dose 21 days to 3 months:
more than or equal to 21 days post third dose to less than 91 days post third dose
Third dose 3+ months:
more than or equal to 91 days post third dose
Model adjustments
Three sets of model adjustments were used
Age adjusted:
age (as a natural spline)
Age, socio-demographics adjusted:
age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status)
Fully adjusted:
age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status), plus health-related characteristics (disability, self-reported health, care home residency, number of QCovid comorbidities (grouped), BMI category, frailty flag and hospitalisation within the last 21 days.
Age
Age in years is defined on the Census day 2021 (21 March 2021). Age is included in the model as a natural spline with boundary knots at the 10th and 90th centiles and internal knots at the 25th, 50th and 75th centiles. The positions of the knots are calculated separately for the overall model and for each age group for the stratified model.
Facebook
TwitterCC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
These documents were produced through a collaboration between GLA, PHE London and Association of Directors of Public Health London. The wider impacts slide set pulls together a series of rapid evidence reviews and consultation conversations with key London stakeholders. The evidence reviews and stakeholder consultations were undertaken to explore the wider impacts of the pandemic on Londoners and the considerations for recovery within the context of improving population health outcomes. The information presented in the wider impact slides represents the emerging evidence available at the time of conducting the work (May-August 2020). The resource is not routinely updated and therefore further evidence reviews to identify more recent research and evidence should be considered alongside this resource. It is useful to look at this in conjunction with the ‘People and places in London most vulnerable to COVID-19 and its social and economic consequences’ report commissioned as part of this work programme and produced by the New Policy Institute. Additional work was also undertaken on the housing issues and priorities during COVID. A short report and examples of good practice are provided here. These reports are intended as a resource to support stakeholders in planning during the transition and recovery phase. However, they are also relevant to policy and decision-making as part of the ongoing response. The GLA have also commissioned the University of Manchester to undertake a rapid evidence review on inequalities in relation to COVID-19 and their effects on London.
Facebook
TwitterOpen Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Odds ratios for the risk of dying from the coronavirus (COVID-19) by ethnicity in England and Wales.
Facebook
TwitterOfficial statistics are produced impartially and free from political influence.